AGM Trading Update and Notice of Interim Results
ECO Animal Health Group PLC reported a strong trading update for the six months ending September 30, 2025, with revenue expected to increase by over 15% compared to H1 2025 revenue of £33.2 million. The China/Japan segment experienced growth greater than 40%, and North America saw growth greater than 25%. The company anticipates improved gross margins, leading to a material increase in adjusted EBITDA compared to the £0.4 million reported in the first half of the prior year. This performance is expected to result in a more balanced weighting between the first and second halves of the year. The company's interim results will be announced in late November 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your EAH notes
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the following trading update for the six months ending 30 September 2025, ahead of its Annual General Meeting being held at 9.00 a.m. this morning.
Trading Update
Trading in the first half of this financial year has been significantly stronger compared to the same period last year despite currency headwinds and tariff challenges, with an expected increase in revenue of over 15% (H1 2025: £33.2 million). This revenue strength has been particularly evident in the China/Japan segment (greater than 40% growth) and North America (greater than 25% growth). Continuing strength in Brazil has been offset by some weakness elsewhere in Latin America. The South East Asia region has recovered much of the ground lost in the prior year.
The Company also expects to report improved gross margins for the period, which will translate into a material increase in adjusted EBITDA compared with the first half of the prior year (H1 2025: £0.4 million).
It is expected that this strength in the first half will result in a more balanced first and second half weighting than has been experienced in recent years and provides the Board with increased confidence of a successful full year outcome in line with current market expectations.1
Interim Results
The Company's interim results for the six-month period ending 30 September 2025 will be announced in late November 2025.
1 The consensus market expectations for revenue and adjusted EBITDA for the year ending 31 March 2026 are £84.2m and £7.9m respectively.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.